Minoryx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Minoryx Therapeutics's estimated annual revenue is currently $6.7M per year.
- Minoryx Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Minoryx Therapeutics has 43 Employees.
- Minoryx Therapeutics grew their employee count by 5% last year.
Minoryx Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
Minoryx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Minoryx Therapeutics?
Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company's lead program, leriglitazone (MIN-102), a novel, selective PPARγ agonist, is currently being evaluated in X-ALD and Friedreich's Ataxia. The company is backed by a syndicate of experienced investors and has support from a network of other organizations. Minoryx was founded in 2011, has operations in Spain and Belgium and has raised a total of €50M through Series A & B financing rounds.
keywords:N/AN/A
Total Funding
43
Number of Employees
$6.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Minoryx Therapeutics News
List of Key Players Covered in the Report: Applied Genetic Technologies Corporation, MedDay SA, Bluebird bio, Inc., Minoryx Therapeutics S.L...
... have their X linked Adrenoleukodystrophy drug candidates in the most advanced stage, i.e. phase II/ III include, Minoryx Therapeutics.
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $31.1M | 124 | 22% | N/A |
#2 | $47.5M | 160 | 42% | N/A |
